Clinical Trial Update: Safety Study of the Hypo-fractionated (Large Doses) Radiation Therapy in Post-menopausal Women With Breast Cancers [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 safety study evaluating hypo-fractionated high-dose radiation therapy in post-menopausal women with breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: NYU Langone Health | Conditions: Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED